NIH Awards $86 Million ($4M for 5 years to Recombinetics) to Improve Genome Editing Techniques Read More
Recombinetics Launches TARGET-TB with Researchers in the Republic of Ireland and Northern Ireland to Develop Genome Editing Solutions for Bovine Tuberculosis Read More
